Menu
GeneBe

ALDH1A3

aldehyde dehydrogenase 1 family member A3, the group of Aldehyde dehydrogenases

Basic information

Region (hg38): 15:100877713-100916626

Previous symbols: [ "ALDH6" ]

Links

ENSG00000184254NCBI:220OMIM:600463HGNC:409Uniprot:P47895AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • isolated microphthalmia 8 (Strong), mode of inheritance: AR
  • isolated microphthalmia 8 (Strong), mode of inheritance: AR
  • isolated anophthalmia-microphthalmia syndrome (Supportive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Microphthalmia, isolated 8ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic; Ophthalmologic23312594

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ALDH1A3 gene.

  • not provided (59 variants)
  • Isolated microphthalmia 8 (45 variants)
  • Inborn genetic diseases (9 variants)
  • not specified (3 variants)
  • Isolated anophthalmia-microphthalmia syndrome (3 variants)
  • Microphthalmia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALDH1A3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
19
clinvar
5
clinvar
24
missense
2
clinvar
6
clinvar
17
clinvar
4
clinvar
1
clinvar
30
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
3
clinvar
1
clinvar
4
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
2
clinvar
2
splice region
1
2
2
5
non coding
16
clinvar
26
clinvar
42
Total 8 7 19 39 32

Highest pathogenic variant AF is 0.0000131

Variants in ALDH1A3

This is a list of pathogenic ClinVar variants found in the ALDH1A3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-100879560-T-A Benign (Aug 03, 2018)1286413
15-100879582-G-A Benign (Nov 10, 2018)1242902
15-100879640-G-A Benign (Aug 03, 2018)1243882
15-100879926-G-C Inborn genetic diseases Uncertain significance (May 17, 2023)2528589
15-100879933-A-T Inborn genetic diseases Uncertain significance (Aug 08, 2023)2596415
15-100879950-A-G Isolated microphthalmia 8 • ALDH1A3-related disorder Benign/Likely benign (Dec 26, 2023)235693
15-100880013-C-A ALDH1A3-related disorder Likely benign (May 08, 2019)3037497
15-100880021-C-T Isolated microphthalmia 8 Likely benign (Mar 28, 2023)1675588
15-100880135-G-A Likely benign (Jul 01, 2022)1711391
15-100880138-C-G Likely benign (Jul 01, 2022)2645748
15-100885138-G-A Likely benign (Dec 09, 2018)1216747
15-100885265-A-G Isolated microphthalmia 8 Pathogenic (Sep 01, 2022)1803003
15-100885290-C-G Isolated microphthalmia 8 • ALDH1A3-related disorder Likely benign (Sep 11, 2023)772098
15-100885337-G-A Inborn genetic diseases Uncertain significance (Dec 08, 2023)3108975
15-100885351-G-T Likely pathogenic (Dec 01, 2016)498816
15-100885376-A-C Isolated microphthalmia 8 Benign (Jan 09, 2023)473868
15-100885414-G-T Benign (Mar 06, 2019)1286007
15-100885498-T-C Benign (Jun 19, 2018)683870
15-100885522-G-A Likely benign (Dec 09, 2018)1198275
15-100885655-C-CT Benign (Sep 01, 2020)1271421
15-100885655-C-CTT Benign (Jun 18, 2021)1246087
15-100887320-GTCAAAAGATGACACCCAAACTGCAGTCACCTCAAAAGATGACACCCAAACTGCAGTCACC-G Likely benign (Sep 11, 2018)1216244
15-100887380-C-G Likely benign (Sep 11, 2018)1199990
15-100887396-G-C Likely benign (Aug 14, 2018)1202224
15-100887515-C-T Likely benign (Feb 22, 2020)1199958

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ALDH1A3protein_codingprotein_codingENST00000329841 1338913
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1410.8591257330151257480.0000596
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.241923010.6370.00001803324
Missense in Polyphen72145.350.495371536
Synonymous0.07331221230.9920.000008281020
Loss of Function3.31623.20.2599.79e-7306

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002990.0000299
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.000.00
European (Non-Finnish)0.00005360.0000527
Middle Eastern0.0001630.000163
South Asian0.00009830.0000980
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: NAD-dependent aldehyde dehydrogenase that catalyzes the formation of retinoic acid (PubMed:27759097). Has high activity with all-trans retinal, and has much lower in vitro activity with acetaldehyde (PubMed:27759097). Required for the biosynthesis of normal levels of retinoic acid in the embryonic ocular and nasal regions; retinoic acid is required for normal embryonic development of the eye and the nasal region (By similarity). {ECO:0000250|UniProtKB:Q9JHW9, ECO:0000269|PubMed:27759097}.;
Pathway
Glycolysis / Gluconeogenesis - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Phenylalanine metabolism - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Ethanol effects on histone modifications;Vitamin A and Carotenoid Metabolism;Signal Transduction;RA biosynthesis pathway;Phenylalanine degradation;retinoate biosynthesis I;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;Tyrosine metabolism;Histidine degradation (Consensus)

Recessive Scores

pRec
0.268

Intolerance Scores

loftool
0.606
rvis_EVS
-0.58
rvis_percentile_EVS
18.72

Haploinsufficiency Scores

pHI
0.257
hipred
Y
hipred_score
0.738
ghis
0.402

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.715

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Aldh1a3
Phenotype
renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
aldh1a3
Affected structure
eye
Phenotype tag
abnormal
Phenotype quality
decreased size

Gene ontology

Biological process
optic cup morphogenesis involved in camera-type eye development;retinoic acid biosynthetic process;locomotory behavior;nucleus accumbens development;embryonic camera-type eye development;inner ear morphogenesis;retinol metabolic process;retinoic acid metabolic process;retinal metabolic process;positive regulation of apoptotic process;embryonic eye morphogenesis;neuromuscular process controlling balance;protein homotetramerization;oxidation-reduction process;righting reflex;olfactory pit development;face development;Harderian gland development
Cellular component
nucleus;cytoplasm;cytosol;plasma membrane;extracellular exosome
Molecular function
retinal dehydrogenase activity;aldehyde dehydrogenase (NAD) activity;aldehyde dehydrogenase [NAD(P)+] activity;protein homodimerization activity;thyroid hormone binding;NAD+ binding